Lisanti Capital Growth LLC Has $2.78 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Lisanti Capital Growth LLC cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 7.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,680 shares of the biotechnology company’s stock after selling 370 shares during the period. Lisanti Capital Growth LLC’s holdings in Axon Enterprise were worth $2,781,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its stake in shares of Axon Enterprise by 19.4% in the third quarter. Farther Finance Advisors LLC now owns 875 shares of the biotechnology company’s stock worth $350,000 after acquiring an additional 142 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in Axon Enterprise by 3.3% in the third quarter. Asset Management One Co. Ltd. now owns 26,642 shares of the biotechnology company’s stock valued at $10,646,000 after purchasing an additional 846 shares in the last quarter. Advisor Resource Council acquired a new position in Axon Enterprise in the 3rd quarter worth about $270,000. BNC Wealth Management LLC raised its stake in shares of Axon Enterprise by 110.8% during the 3rd quarter. BNC Wealth Management LLC now owns 10,379 shares of the biotechnology company’s stock worth $4,147,000 after purchasing an additional 5,456 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after buying an additional 33,869 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AXON has been the topic of several recent research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective for the company. in a report on Thursday, February 20th. Northland Securities increased their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Trading Down 6.7 %

Shares of AXON opened at $499.31 on Friday. The stock’s 50-day moving average price is $603.60 and its 200 day moving average price is $527.57. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $38.07 billion, a price-to-earnings ratio of 129.02, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.